{
    "2019-01-09": [
        [
            {
                "time": "2019",
                "original_text": "【2019年重点个股】智飞生物：营销强者，多个重磅品种助力持续高增长",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "营销",
                        "重磅品种",
                        "高增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019",
                "original_text": "医药行业周报:卫健委部署2019年卫生健康改革十大重点任务",
                "features": {
                    "keywords": [
                        "卫健委",
                        "卫生健康改革",
                        "重点任务"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019",
                "original_text": "医药生物行业2019年投资策略:创新才是硬道理",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资策略",
                        "创新"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019",
                "original_text": "医药周报2019第2期:并购大事件,危与机并存",
                "features": {
                    "keywords": [
                        "医药",
                        "并购",
                        "危与机"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019",
                "original_text": "医药行业周报:“轻药重医”为正道",
                "features": {
                    "keywords": [
                        "医药",
                        "轻药重医"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}